GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Scaled Net Operating Assets

Tauns Laboratories (TSE:197A) Scaled Net Operating Assets : 0.75 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tauns Laboratories's operating assets for the quarter that ended in Jun. 2024 was 円19,836 Mil. Tauns Laboratories's operating liabilities for the quarter that ended in Jun. 2024 was 円6,056 Mil. Tauns Laboratories's Total Assets for the quarter that ended in Jun. 2023 was 円18,332 Mil. Therefore, Tauns Laboratories's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.75.


Tauns Laboratories Scaled Net Operating Assets Historical Data

The historical data trend for Tauns Laboratories's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Scaled Net Operating Assets Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
Scaled Net Operating Assets
0.29 0.68 0.75

Tauns Laboratories Semi-Annual Data
Jun22 Jun23 Jun24
Scaled Net Operating Assets 0.29 0.68 0.75

Competitive Comparison of Tauns Laboratories's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's Scaled Net Operating Assets falls into.


;
;

Tauns Laboratories Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Tauns Laboratories's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2024 )
=(Operating Assets (A: Jun. 2024 )-Operating Liabilities (A: Jun. 2024 ))/Total Assets (A: Jun. 2023 )
=(19836.434-6055.567)/18332.162
=0.75

where

Operating Assets(A: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=29261.325 - 9424.891
=19836.434

Operating Liabilities(A: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=15594.567 - 4307 - 5232
=6055.567

Tauns Laboratories's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Jun. 2023 )
=(19836.434-6055.567)/18332.162
=0.75

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=29261.325 - 9424.891
=19836.434

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=15594.567 - 4307 - 5232
=6055.567

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tauns Laboratories Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines